I was wrong, it was 1998, that human embryonic stem cells were first isolated, by Dr. Thompson at Wisconsin. Sorry I was off by 2 years.
Thomson's research
Since joining the Wisconsin Regional Primate Research Center, he has conducted pioneering work in the isolation and culture of non-human primate and human embryonic stem cells, undifferentiated cells that have the ability to become any of the cells that make up the tissues of the body. Dr. Thomson directed the group that reported the first isolation of embryonic stem cell lines from a non-human primate in 1995, work that led his group to the first successful isolation of human embryonic stem cell lines in 1998.
On November 6, 1998, Science published the results of his research, "Embryonic Stem Cell Lines Derived from Human Blastocysts". [1] Thomson's research was not subject of any federal funds, but sparked a debate about the ability of the National Institute of Health's ability to fund human embryonic stem cell research.
Both the non-human primate and human embryonic stem cells issued as patents. The patents were assigned to the Wisconsin Alumni Research Foundation. Since the primate stem cells were funded with a federal grant, the Federal government has a non-exclusive, non-transferable paid up license under the Bayh-Dole Act. The human embryonic stem cells were funded privately by Geron Corp. and by a grant from WARF. Geron now has an exclusive license to six of the cell lines.
After the patent issued for human embryonic stem cells, Time put Thomson on the cover. [2]
[edit]
Thomson's research
Since joining the Wisconsin Regional Primate Research Center, he has conducted pioneering work in the isolation and culture of non-human primate and human embryonic stem cells, undifferentiated cells that have the ability to become any of the cells that make up the tissues of the body. Dr. Thomson directed the group that reported the first isolation of embryonic stem cell lines from a non-human primate in 1995, work that led his group to the first successful isolation of human embryonic stem cell lines in 1998.
On November 6, 1998, Science published the results of his research, "Embryonic Stem Cell Lines Derived from Human Blastocysts". [1] Thomson's research was not subject of any federal funds, but sparked a debate about the ability of the National Institute of Health's ability to fund human embryonic stem cell research.
Both the non-human primate and human embryonic stem cells issued as patents. The patents were assigned to the Wisconsin Alumni Research Foundation. Since the primate stem cells were funded with a federal grant, the Federal government has a non-exclusive, non-transferable paid up license under the Bayh-Dole Act. The human embryonic stem cells were funded privately by Geron Corp. and by a grant from WARF. Geron now has an exclusive license to six of the cell lines.
After the patent issued for human embryonic stem cells, Time put Thomson on the cover. [2]
[edit]